Over the past three decades, many methods have been developed to evaluate levels of
biomarkers in autoimmune diseases. Early investigations have shown that some biomarkers …

Multiple sclerosis (MS) is a demyelinating and neurodegenerative autoimmune disease of
the central nervous system (CNS) damaging myelin and axons. Diagnosis is based on the …

Background To reduce the risk of long-term disability in people with Multiple Sclerosis
(pwMS), an increasing number of disease-modifying immune therapies (DMT) are available …

Purpose This study aims to identify the key factors influencing health-related quality of life
(HRQoL) of pediatric acute myeloid leukemia (AML) patients following their initial diagnosis …

Introduction Multiple sclerosis (MS) is a neurodegenerative disease characterized by
progressive deterioration of cognitive and physical functioning, reducing activities of daily …

Background MS severity may be affected by genetic, patient-related, disease-related and
environmental factors. Socioeconomic status, including income and healthcare access …

Objectives We have analyzed the association of delayed both diagnosis and treatment of
persons with MS with the long-term results of patients given aHSCT. Methods Patients with …

Objectives We have analyzed the association of delayed both diagnosis and treatment of
persons with MS with the long-term results of patients given autologous hematopoietic stem …

Introducción En la actualidad existe un importante número de opciones en terapias
modificadoras de la enfermedad en esclerosis múltiple (EM), las cuales pueden ser …

Bei der Multiplen Sklerose ist die frühe Diagnose und Prognoseabschätzung eine wichtige
Voraussetzung für eine möglichst frühe und gezielte effektive Therapie. Auch wenn kein …